288 related articles for article (PubMed ID: 12125844)
1. A retrospective analysis of long-term survival in severe aplastic anemia patients treated with allogeneic bone marrow transplantation or immunosuppressive therapy with antithymocyte globulin and cyclosporin A at a single institution.
Ellis RJ; Kahn Q; Skikne BS; Mayo MS; Allgood JW; Bodensteiner DM; Deauna-Limayo D; Cook JD
Mil Med; 2002 Jul; 167(7):541-5. PubMed ID: 12125844
[TBL] [Abstract][Full Text] [Related]
2. Comparison of long-term outcome of children with severe aplastic anemia treated with immunosuppression versus bone marrow transplantation.
Gillio AP; Boulad F; Small TN; Kernan NA; Reyes B; Childs BH; Brochstein JA; Laver J; Castro-Malaspina H; O'Reilly RJ
Biol Blood Marrow Transplant; 1997 Apr; 3(1):18-24. PubMed ID: 9209737
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcome of acquired aplastic anaemia in children: comparison between immunosuppressive therapy and bone marrow transplantation.
Kojima S; Horibe K; Inaba J; Yoshimi A; Takahashi Y; Kudo K; Kato K; Matsuyama T
Br J Haematol; 2000 Oct; 111(1):321-8. PubMed ID: 11091219
[TBL] [Abstract][Full Text] [Related]
4. Single institution outcomes of treatment of severe aplastic anaemia.
Mollee P; Woodward N; Durrant S; Lockwood L; Gillett EA; Morton J; Rowell J
Intern Med J; 2001 Aug; 31(6):337-42. PubMed ID: 11529587
[TBL] [Abstract][Full Text] [Related]
5. Clinical results in 50 multiply transfused patients with severe aplastic anemia treated with bone marrow transplantation or immunosuppressive therapy.
Arranz R; Otero MJ; Ramos R; Steegmann JL; Lamana ML; Tomás JF; de la Cámara R; Figuera A; Vázquez L; Fernádez-Rañada JM
Bone Marrow Transplant; 1994 Apr; 13(4):383-7. PubMed ID: 8019461
[TBL] [Abstract][Full Text] [Related]
6. Similar outcome of upfront-unrelated and matched sibling stem cell transplantation in idiopathic paediatric aplastic anaemia. A study on behalf of the UK Paediatric BMT Working Party, Paediatric Diseases Working Party and Severe Aplastic Anaemia Working Party of EBMT.
Dufour C; Veys P; Carraro E; Bhatnagar N; Pillon M; Wynn R; Gibson B; Vora AJ; Steward CG; Ewins AM; Hough RE; de la Fuente J; Velangi M; Amrolia PJ; Skinner R; Bacigalupo A; Risitano AM; Socie G; Peffault de Latour R; Passweg J; Rovo A; Tichelli A; Schrezenmeier H; Hochsmann B; Bader P; van Biezen A; Aljurf MD; Kulasekararaj A; Marsh JC; Samarasinghe S
Br J Haematol; 2015 Nov; 171(4):585-94. PubMed ID: 26223288
[TBL] [Abstract][Full Text] [Related]
7. Immunosuppressive therapy: a potential alternative to bone marrow transplantation as initial therapy for acquired severe aplastic anemia in childhood?
Lawlor ER; Anderson RA; Davis JH; Fryer CJ; Pritchard SL; Rogers PC; Wu JK; Schultz KR
J Pediatr Hematol Oncol; 1997; 19(2):115-23. PubMed ID: 9149740
[TBL] [Abstract][Full Text] [Related]
8. [Immunosuppressive therapy using antithymocyte globulin and cyclosporin A with or without human granulocyte colony-stimulating factor in children with acquired severe aplastic anemia].
Liu X; Zou Y; Wang S; Zhang L; Yang W; Zhang J; Liu F; Liu T; Chen X; Ruan M; Zhou J; Cai X; Qi B; Chang L; An W; Guo Y; Chen Y; Zhu X
Zhonghua Er Ke Za Zhi; 2014 Feb; 52(2):84-9. PubMed ID: 24739716
[TBL] [Abstract][Full Text] [Related]
9. The efficacy of rabbit antithymocyte globulin with cyclosporine in comparison to horse antithymocyte globulin as a first-line treatment in adult patients with severe aplastic anemia: a single-center retrospective study.
Shin SH; Yoon JH; Yahng SA; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Kim HJ; Cho SG; Kim DW; Min WS; Park CW; Lee JW
Ann Hematol; 2013 Jun; 92(6):817-24. PubMed ID: 23318980
[TBL] [Abstract][Full Text] [Related]
10. Treatment of adults with severe aplastic anemia: primary therapy with antithymocyte globulin (ATG) and rescue of ATG failures with bone marrow transplantation.
Crump M; Larratt LM; Maki E; Curtis JE; Minden MD; Meharchand JM; Lipton JH; Messner HA
Am J Med; 1992 Jun; 92(6):596-602. PubMed ID: 1605140
[TBL] [Abstract][Full Text] [Related]
11. Cyclophosphamide and antithymocyte globulin as a conditioning regimen for allogeneic marrow transplantation in patients with aplastic anaemia: a long-term follow-up.
Kahl C; Leisenring W; Deeg HJ; Chauncey TR; Flowers ME; Martin PJ; Sanders JE; Storb R
Br J Haematol; 2005 Sep; 130(5):747-51. PubMed ID: 16115132
[TBL] [Abstract][Full Text] [Related]
12. The treatment of severe aplastic anemia: outcomes of bone marrow transplantation and immunosuppressive therapy in a single institution of Korea.
Kim I; Yoon SS; Park S; Kim BK; Kim NK
J Korean Med Sci; 2003 Jun; 18(3):365-71. PubMed ID: 12808323
[TBL] [Abstract][Full Text] [Related]
13. Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. German/Austrian Pediatric Aplastic Anemia Working Group.
Führer M; Burdach S; Ebell W; Gadner H; Haas R; Harbott J; Janka-Schaub G; Klingebiel T; Kremens B; Niemeyer C; Rampf U; Reiter A; Ritter J; Schulz A; Walther U; Zeidler C; Bender-Götze C
Klin Padiatr; 1998; 210(4):173-9. PubMed ID: 9743949
[TBL] [Abstract][Full Text] [Related]
14. Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome.
Rosenfeld S; Follmann D; Nunez O; Young NS
JAMA; 2003 Mar; 289(9):1130-5. PubMed ID: 12622583
[TBL] [Abstract][Full Text] [Related]
15. First-line treatment for severe aplastic anemia in children: bone marrow transplantation from a matched family donor versus immunosuppressive therapy.
Yoshida N; Kobayashi R; Yabe H; Kosaka Y; Yagasaki H; Watanabe K; Kudo K; Morimoto A; Ohga S; Muramatsu H; Takahashi Y; Kato K; Suzuki R; Ohara A; Kojima S
Haematologica; 2014 Dec; 99(12):1784-91. PubMed ID: 25193958
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcome of pediatric patients with severe aplastic anemia treated with antithymocyte globulin and cyclosporine.
Scheinberg P; Wu CO; Nunez O; Young NS
J Pediatr; 2008 Dec; 153(6):814-9. PubMed ID: 18672253
[TBL] [Abstract][Full Text] [Related]
17. Effect of antithymocyte globulin source on outcomes of bone marrow transplantation for severe aplastic anemia.
Kekre N; Zhang Y; Zhang MJ; Carreras J; Ahmed P; Anderlini P; Atta EH; Ayas M; Boelens JJ; Bonfim C; Deeg HJ; Kapoor N; Lee JW; Nakamura R; Pulsipher MA; Eapen M; Antin JH
Haematologica; 2017 Jul; 102(7):1291-1298. PubMed ID: 28341733
[TBL] [Abstract][Full Text] [Related]
18. The benefit of ATG in immunosuppressive therapy of children with moderate aplastic anemia.
Jiang S; Wang Y; Shi W; Shao Y; Qiao X; Lin J; Kuang H; Xie X
Pediatr Hematol Oncol; 2009; 26(5):313-20. PubMed ID: 19579077
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens.
Champlin RE; Perez WS; Passweg JR; Klein JP; Camitta BM; Gluckman E; Bredeson CN; Eapen M; Horowitz MM
Blood; 2007 May; 109(10):4582-5. PubMed ID: 17272503
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up of allogeneic marrow transplants in patients with aplastic anemia conditioned by cyclophosphamide combined with antithymocyte globulin.
Storb R; Leisenring W; Anasetti C; Appelbaum FR; Buckner CD; Bensinger WI; Chauncey T; Clift RA; Deeg HJ; Doney KC; Flowers ME; Hansen JA; Martin PJ; Sanders JE; Sullivan KM; Witherspoon RP
Blood; 1997 May; 89(10):3890-1. PubMed ID: 9160700
[No Abstract] [Full Text] [Related]
[Next] [New Search]
